Back to top
more

PerkinElmer, Inc. (PKI)

(Delayed Data from NYSE)

$96.59 USD

96.59
692,880

+1.71 (1.80%)

Updated May 3, 2019 04:03 PM ET

After-Market: $96.59 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Here's Why You Should Retain McKesson (MCK) Stock for Now

by Zacks Equity Research

McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.

PerkinElmer's Tie-Up to Boost Health Outcomes in Africa

by Zacks Equity Research

PerkinElmer's (PKI) partnership with ASH likely to boost newborn screening in underserved populations for better health outcomes in Africa.

Why Is PerkinElmer (PKI) Up 11.4% Since Last Earnings Report?

by Zacks Equity Research

PerkinElmer (PKI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why You Should Retain PerkinElmer (PKI) in Your Portfolio

by Zacks Equity Research

PerkinElmer (PKI) continues to gain traction from strong international presence and robust product portfolio.

PerkinElmer (PKI) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

PerkinElmer's (PKI) first-quarter results benefit from growth in Discover & Analytics Solutions segment. However, forex remains a woe.

PerkinElmer (PKI) Q1 Earnings and Revenues Beat Estimates

by Zacks Equity Research

PerkinElmer (PKI) delivered earnings and revenue surprises of 42.55% and 1.75%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Aniruddha Ganguly headshot

Drab Near-Term Prospects for Scientific Instruments Industry

by Aniruddha Ganguly

The Zacks Instruments - Scientific industry is witnessing a slump in demand for instruments as laboratories and research facilities remain closed in the wake of the pandemic predicament.

PerkinElmer (PKI) to Report Q1 Earnings: What's in Store?

by Zacks Equity Research

PerkinElmer's (PKI) first-quarter results likely to reflect top-line growth and robust performance at Diagnostics segment. However, forex is likely to have remained a woe.

Analysts Estimate PerkinElmer (PKI) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

PerkinElmer (PKI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Luminex (LMNX) Receives EUA for Coronavirus Detection Test

by Zacks Equity Research

Luminex (LMNX) receives EUA for its ARIES SARS-CoV-2 Assay, which will be used to rapidly detect the virus causing COVID-19.

BD Gets EUA for New Test to Combat the Coronavirus Crisis

by Zacks Equity Research

BD (BDX) partners with BioGX to introduce a new diagnostic test to help hospitals boost the capacity of quick, on-site testing of COVID-19.

BD Launches New Test to Help Combat the Coronavirus Outbreak

by Zacks Equity Research

BD (BDX), along with BioMedomics, launches a new point-of-care test to help fight the coronavirus outbreak.

Sriparna Ghosal headshot

FDA EUA for Coronavirus Tests Boosts MedTech: 3 Stocks in Focus (Revised)

by Sriparna Ghosal

These key biotech and molecular diagnostic players banking on the receipt of FDA's EUA for COVID-19 tests are currently outperforming the broader industries they belong to.

Sriparna Ghosal headshot

FDA EUA for Coronavirus Tests Boosts MedTech: 3 Stocks in Focus

by Sriparna Ghosal

These key biotech and molecular diagnostic players banking on the receipt of FDA's EUA for COVID-19 tests are currently outperforming the broader industries they belong to.

Here's Why You Should Hold On to PerkinElmer (PKI) Stock Now

by Zacks Equity Research

PerkinElmer (PKI) expects to witness foreign exchange headwinds in 2020.

    PerkinElmer (PKI) Receives EUA for Coronavirus Detection Test

    by Zacks Equity Research

    PerkinElmer (PKI) introduces test for the detection of coronavirus after it receives EUA for the same.

    PerkinElmer (PKI) Down 12.1% Since Last Earnings Report: Can It Rebound?

    by Zacks Equity Research

    PerkinElmer (PKI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

    PerkinElmer (PKI) Q4 Earnings and Revenues Beat Estimates

    by Zacks Equity Research

    PerkinElmer's (PKI) Q4 earnings benefits from higher revenues and growth in DAS and Diagnostics segments. However, forex remains a woe.

    PerkinElmer (PKI) Tops Q4 Earnings and Revenue Estimates

    by Zacks Equity Research

    PerkinElmer (PKI) delivered earnings and revenue surprises of 2.27% and 0.44%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

    PerkinElmer (PKI) to Report Q4 Earnings: What's in the Cards?

    by Zacks Equity Research

    Top-line growth and robust performance at Diagnostics segment are likely to have aided PerkinElmer's (PKI) Q4 earnings. However, forex is likely to have remained a woe.

    PerkinElmer (PKI) Reports Next Week: Wall Street Expects Earnings Growth

    by Zacks Equity Research

    PerkinElmer (PKI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Waters to Buy Andrew Alliance, Expand Technology Portfolio (Revised)

    by Zacks Equity Research

    Waters (WAT) agrees to acquire Andrew Alliance in a bid to expand technology portfolio.

    Aniruddha Ganguly headshot

    Scientific Instruments Industry Outlook: Prospects Look Good

    by Aniruddha Ganguly

    The Zacks Instruments - Scientific industry is benefiting from solid prospects in emerging markets, robust end-market demand and increasing spending on health care.

    Here's Why You Should Hold on to PerkinElmer Stock for Now

    by Zacks Equity Research

    PerkinElmer (PKI) is gaining steadily from the core Diagnostics segment, prudent acquisitions and margin expansion. However, forex volatility remains a concern.

    PerkinElmer (PKI) Q3 Earnings Beat Estimates, Revenues Miss

    by Zacks Equity Research

    PerkinElmer's (PKI) Q3 earnings benefits from higher revenues and growth in DAS and Diagnostics segments. However, forex remains a woe.